Similar articles

• Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.

  Spieker C, Vetter W, Zidek W, Vetter H. Spieker C, et al. Arzneimittelforschung. 1989 Nov;39(11A):1512-4. Arzneimittelforschung. 1989. PMID: 2576202
• [Value of a blood pressure profile in evaluating 2 antihypertensive agents].

  Abetel G, Mérier G, Karly M, Genoud A, Bousquet JC. Abetel G, et al. Schweiz Med Wochenschr. 1984 Dec 1;114(48):1746-9. Schweiz Med Wochenschr. 1984. PMID: 6151741 Clinical Trial. French.
• [The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension].

  Török E, Jávor T, Szám I, Gábor G. Török E, et al. Orv Hetil. 1976 Mar 7;117(10):593-8. Orv Hetil. 1976. PMID: 1250586 Hungarian. No abstract available.
• [Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].

  Lil'in ET, Vavilova TA, Mar'in MI. Lil'in ET, et al. Klin Med (Mosk). 1983 Sep;61(9):85-9. Klin Med (Mosk). 1983. PMID: 6139506 Review. Russian. No abstract available.
• Hypertension and beta-blockers. Are they all the same?

  Raftery EB, Carrageta MO. Raftery EB, et al. Int J Cardiol. 1985 Apr;7(4):337-46. doi: 10.1016/0167-5273(85)90089-0. Int J Cardiol. 1985. PMID: 2859251 Review.